Journal article

Surgical treatment of fibrolamellar hepatocellular carcinoma: An underestimated malignant tumor?

P Herman, AL Chagas, MV Perini, FF Coelho, GM Fonseca, VAF Alves, FJ Carrilho, I Cecconello

Hepatobiliary and Pancreatic Diseases International | ZHEJIANG UNIV SCH MEDICINE | Published : 2014

Abstract

BACKGROUND Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare disease with an indolent behavior. Its prognosis is better than that of patients with hepatocellular carcinoma. The authors present their experience with resection of FLHCC. METHODS Twenty-one patients with FLHCC were treated at our institution between 1990 and 2012. Of these patients, 14 were subjected to resection of the tumor. Patient demographics, medical history, results of imaging studies and laboratory tests, surgical data, and pathologic findings were evaluated. RESULTS The median age of the patients at the diagnosis of the tumor was 20 years and 14 patients were female. None of the patients had tumor-associated chro..

View full abstract

University of Melbourne Researchers